You just read:

Eiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and Japan

News provided by

Eiger BioPharmaceuticals, Inc.

Feb 06, 2019, 08:00 ET